Oceanic cyanobacteria are the most abundant oxygen-generating phototrophs on our planet and are therefore important to life. These organisms are infected by viruses called cyanophages, which have recently shown to encode metabolic genes that modulate host photosynthesis, phosphorus cycling and nucleotide metabolism. Herein we report the characterization of a wildtype flavin-dependent viral halogenase (VirX1) from a cyanophage. Notably, halogenases have been previously associated with secondary metabolism, tailoring natural products. Exploration of this viral halogenase reveals it capable of regioselective halogenation of a diverse range of substrates with a preference for forming aryl iodide species; this has potential implications for the metabolism of the infected host. Until recently, a flavin-dependent halogenase that is capable of iodination in vitro had not been reported. VirX1 is interesting from a biocatalytic perspective as it shows strikingly broad substrate flexibility and a clear preference for iodination, as illustrated by kinetic analysis. These factors together render it an attractive tool for synthesis.
T he selective formation of carbon-halogen (C-X) bonds is of great importance to the pharmaceutical and agrochemical industries 1, 2 . The introduction of a halogen into a molecule can be used to modulate bioactivity, bioavailability and metabolic stability [1] [2] [3] . Traditional chemical methods of halogenating aromatic substrates generally employ highly reactive reagents and generate harmful waste. As traditional reagents lack components that enable the tuning of product selectivity, they often generate products in which either only the most nucleophilic positions are halogenated or mixtures of products are produced. Conversely, biosynthetic (enzymatic) halogenation is mild, highly selective and uses simple salts such as NaCl or NH 4 Br as a halide source whereas oxygen serves as the oxidant [1] [2] [3] . Consequently, the discovery and structural characterization of flavin-dependent halogenases (FDHs) that are capable of selectively forming C-Cl and C-Br bonds 4, 5 and the discovery of an S-adenosylmethionine-dependent fluorinase 6 that is able to mediate nucleophilic C-F bond formation attracted considerable attention. A FDH that is capable of generating C-I bonds was not discovered and characterized until recently 7 .
The FDHs that have previously been studied are predominantly drawn from a limited number of well-known phyla 2, 3, 7, 8 . It may be seen through branching analysis of protein sequences that a correlation exists between the protein sequence and substrate preference. Such preference includes the presentation of the substrate; that is, whether or not it is covalently tethered to an associated enzyme ( Fig. 1 ). Almost all previously discovered FDHs have been determined due to their role in the generation of halogenated natural products [2] [3] [4] [5] [6] [7] [8] [9] . Many of these metabolites arise from well-studied bacteria (especially actinomycetes) or fungi. As halogenases only from a very limited series of organisms have been explored so far, their natural substrate specificity has been limited. Considerable effort has been invested into the rational redesign and directed evolution of these enzymes to expand or change the substrate specificity [10] [11] [12] [13] [14] .
Results and discussion
Bioinformatics-based discovery of VirX1. We adopted a bioinformatics-based approach to break from this trend in halometabolite-led identification of enzymes. Having compiled data from all fully biochemically and structurally characterized FDH enzymes, sequence alignment enabled us to see both of the known GxGxxG and WxWxIP motifs 4 , as well as a previously unnoticed Fx.Px.Sx.G motif (where 'x' is any amino acid and each '. ' independently represents the number of x between each conserved residue and can be any number: 0, 1, 2 and so on) 15 . Although GxGxxG and WxWxIP motifs have hitherto been used to indicate the presence of FDHs, GxGxxG could as readily indicate flavin-monooxygenase-related enzymes and the WxWxIP motif is known to be absent in more unusual FDHs such as Bmp5 16 . The Fx.Px.Sx.G motif may be used by itself to mine for halogenases from uncurated genome sequences 15 .
Using our motif as a probe, we revealed the presence of an open reading frame-deposited as 'hypothetical protein CPUG_00131'in the cyanophage Syn10, a broad host range cyanophage with a 177 kbp genome that is known to infect Prochlorococcus and Synechococcus 17 ; we named the encoded protein VirX1. Aligned against known halogenases, VirX1 shows low similarity to the wellstudied tryptophan 7-halogenases PrnA and RebH (29% and 31% respectively). It may therefore be classified as being in the twilight zone of sequence similarity 18 . Generation of a homology structural model of VirX1 using Phyre2 19 and comparative analysis of this to PrnA and all other structurally characterized halogenases revealed a pyramid-and-box-shape structure that is characteristic of tryptophan halogenases 4 . However, the model of VirX1 indicated the presence of a higher number of loops in the C-terminal domain of VirX1, potentially enabling larger conformational changes following substrate binding and enhanced substrate specificity compared with typical tryptophan halogenases. The active site could be identified from the position of the Fx.Px.Sx.G motif as well as the cofactor binding site GxGxxG.
Iodination activity, substrate scope and kinetics of VirX1. We set out to explore whether the encoded protein was indeed an active halogenase and, if so, whether it might show useful biocatalytic utility, including substrate flexibility. To this end, we screened the halogenase against a 400-member library containing substrates that would sterically and electronically challenge the potential catalyst, using liquid chromatography-high resolution mass spectrometry (LC-HRMS) and ultra-performance liquid chromatography (UPLC) to validate the generation of new halogenated products. Under the conditions of our assay, the enzyme showed very poor activity in chlorinating substrates, but good bromination activity and a surprising preference for iodination. The wild-type enzyme demonstrated striking substrate flexibility ( Fig. 2 ). From this 400-member library, it was determined that 32 sterically and electronically diverse compounds could be accepted as substrates with 1-95% conversion (Fig. 2 ). For each substrate that was processed, LC-HRMS analysis indicated that biotransformative halogenation only resulted in the formation of a monoiodinated product. For the majority of substrates, only a single regioisomer was observed. Enzymatic halogenation could be seen to be mediated on several less reactive or challenging substrates (including (poly)heterocycles (5) 20 , azaspirocycles (14) 21 or bathophenanthroline (30)) that were not readily iodinated using synthetic conditions at room temperature. Fourteen of these products were selected on the basis of both structural interest and conversion level for further analysis, including spectroscopic structural characterization. This analysis revealed that although halogenation was often mediated at the most chemically reactive position, this was not always the case; for example, enzymatic products 3, 5, 7, 8, 12 and 14 did not match with synthetic iodostandards that were prepared by electrophilic iodination, indicating the possibility of different regioisomers being formed ( Fig. 2 ). Steady-state kinetic analysis of the enzyme-catalysed reaction was carried out for twelve of these substrates (Table 1) .
Kinetic analysis revealed the enzyme to have preference for iodide over bromide (Table 1 ). This is unprecedented as there has been no previous characterization of FDHs with a clear natural preference for iodination in vitro. Previous reports exploring whether RebH might mediate iodination revealed through halide competition assays that the introduction of NaI prevented the formation of any chlorinated product, yet no iodinated product was observed 22 . Conversely, in the competition assays that we explored with VirX1 using equivalent concentrations of NaI, NaBr and NaCl, only the iodinated product could be detected ( Supplementary Fig. 17 ). Under the conditions of our assay, and with all substrates explored, the preference for the halide shown by VirX1 is I > Br > Cl, which corresponds to the decreasing oxidative potential of the halide.
PltM halogenase 7 has recently been reported to be flexible in terms of halide versatility, permissibly enabling iodination of phenolic substrates. Spectroscopic characterization of the iodinated compounds produced by PltM was not reported (possibly due to the notorious instability of iodinated compounds precluding isolation) nor were any kinetics reported for the reaction as the enzyme was seen to precipitate in the presence of NaI, indicating poor tolerance to this halide 19 . This versatility of halide utilization observed for PltM-in which iodination is permissible-is perhaps more extensive. In this study, we showed that although PrnA could not iodinate its natural substrate tryptophan, discernible levels of iodination were evident with a number of its unnatural substrates, though typically at ~1% conversion (Supplementary Table 6 ). We explored whether PrnA might also mediate halogenation of substrates that are processed by VirX1. We saw that PrnA could process many of the substrates to a low level. It may be that many of the FDHs-in addition to PrnA and PltM-could be capable of very limited or trace iodination in the presence of certain substrates.
VirX1, however, shows very clear iodination activity. Specifically, iodination by VirX1 of a modest/non-native substrate 6-azaindole (1) proceeds with a k cat of 5 min −1 (k cat /K m of 0.18 min −1 µM −1 ) whereas PrnA's chlorination of its natural substrate progresses more slowly with a k cat of 0.093 min −1 (k cat /K m of 0.0006 min −1 µM −1 ) 4 . Synthetic halogenation of 6-azaindole (1) The viral iodinase VirX1 (highlighted in purple alongside the arrow) is predicted to branch away from the tryptophan chlorinases and brominases while still being associated with their cluster. The analysis highlights the evolved differences in the halide preference and correspondingly grouped substrate preferences of these FDHs. The diagram is represented as an unrooted circular phylogram in which nodes (shown as coloured circles) represent each individual amino acid sequence analysed, and the branches (the lines connecting them) represent the degree of evolutionary divergence (for example, the number of amino acid substitutions, deletions or insertions that have occurred between connected branch points). A global alignment of the full-length amino acid sequences of VirX1 with other known FDHs and non-FDH flavoenzymes (used as an outgroup) was used to construct the branching diagram (through application of the neighbour-joining method), applying the Kimura algorithm for protein distance measurements. Bootstrapping analysis was performed in 100 replicates.
generation of a diiodinated product (with HOI) and a series of other products; for example, in reaction with HOBr, a dimer of bromo-6-azaindole was observed by LCMS ( Supplementary Scheme 1) .
Conversely the VirX1 catalysed reaction yields only the monoiodinated or monobrominated product as a single regioisomer.
The structure of VirX1. We next sought to structurally investigate VirX1. Purification of the protein enabled X-ray crystallographic analysis of the apo structure that revealed six monomers of VirX1 in the asymmetric unit ( Fig. 3a) , all of which showed the highest structural similarity to the PrnA E450K structure (Dali search;
highest Z-score = 47.1; PDB ID: 4Z43) that shares the box and pyramid architecture in agreement with our bioinformatics predictions 4, 23 . The six monomers in the asymmetric unit are predicted by jsPISA 2.0.5 (ref. 24 ) to form two stable trimeric assemblies ( Fig. 3b ; ΔG diss = ~42.6 kcal mol −1 , where ΔG diss is the Gibbs energy of dissociation) with protein-protein interfaces that cover an area of 10,486.4 Å 2 per trimer (Fig. 3) . The trimeric state of VirX1 was confirmed by analytical size exclusion chromatography, revealing an apparent molecular weight of VirX1 of around 180 kDa in solution, as well as by size-excluion chromatography multiangle light scattering ( Supplementary Fig. 13 and Supplementary Table 4 ) Biocatalytic halogenation using VirX1 on a 400-member compound library revealed 32 compounds that were accepted as substrates. The enzyme is shown to monohalogenate a diverse range of sterically and electronically different substrates. Fourteen substrates (boxed) were selected on the basis of both interest in the product and their stability for further verification by either scale-up and spectroscopic characterization of their product or by comparison to synthetic standards that we generated and fully characterized. Iodinated products 1 and 2 were isolated from VirX1 biotransformations, whereas the regiochemistries for 3-14 were determined by comparison with synthetic standards. The asterisks denote hypothesized halogenation sites by VirX1 where the enzymatic product did not match with synthetic standards. Conversion levels to the iodinated product are reported, as estimated by LC-HRMS or UPLC analysis. and analytical ultracentrifugation ( Supplementary Fig. 14 and Supplementary Table 5 ). The trimer forms a bowl-shaped assembly, with one substrate binding site per monomer that flanks the insides of the bowl (Fig. 3c,d) .
The structure of VirX1 shows many similarities to other FDHs with the box-shaped flavin binding module (required for flavin binding and generation of the hypohalous acid electrophile) being almost identically folded (Fig. 4a ). Both K79 and E358, implicated in haloamine formation and in deprotonation of the Wheland intermediate, respectively, occupy similar positions to K79 and E346 in the active site of PrnA (Fig. 4b) . The positionings of F99 and Y97 are similar to those seen for F103 and H101 in PrnA complexing the tryptophan (Trp), Cl and FAD (PDB ID: 2AQJ) ligands, which are believed to stabilize the Wheland intermediate 4 . Assay with monochlorodimedone 4 indicated that the halogenating species must be enzyme bound ( Supplementary Figs. 18 and 19 ). Site-directed mutagenesis was carried out to identify key catalytic residues, and although the mutants K79A, K79R, F353A, S359A and P356A all yielded soluble proteins (that eluted in a very similar manner to wild-type VirX1, suggesting correct folding of these mutants), each of these mutants were determined to be completely inactive in catalysing halogenation of 6-azaindole (1) with either NaI or NaBr, reinforcing the importance of these residues for the enzyme's catalytic activity ( Supplementary Fig. 16 ).
As anticipated, with all key catalytic residues in place, the α-helical pyramid-shaped substrate module displays a different arrangement of secondary structure elements to its closest structural homologue PrnA (Fig. 4a ). Key differences include the absence of the α-helical lid that is required for tryptophan halogenases (T435-W455 in PrnA) to close off the tryptophan binding site (as seen in BrvH) 25 (Fig. 4c) . The substrate binding site of VirX1 displays an even wider opening than BrvH, providing a possible explanation for the wide substrate scope, and the ability to accommodate a halide with a larger van der Waals radius (Fig. 4c ). Further expansion of the putative substrate binding site is enabled by the increased distance of α17 and α18 from the catalytic residues in it. A further key difference to PrnA, RebH and BrvH is an additional loop (P432-Q442) taking part in the trimer interface through a hydrogen-bonding network (Fig. 3b) , opening up access to the substrate binding site (Fig. 4) .
To further explore the VirX1 substrate binding mode, many attempts were made to crystallize VirX1 in complex with various substrates. However, these did not yield sufficiently diffracting crystals for structural analysis, therefore in silico methods were explored instead. Given the subjectivity of in silico small-molecule protein docking experiments, several complementary approaches were explored with both rigid and flexible models of VirX1. Table 2 ). The choice of hypothetical binding modes ( Supplementary Figs. 1-11 ) was mainly informed by proximity of the putatively halogenated carbon to K79 that would form and position the iodamine for reaction with the substrate and E358, which would stabilize the Wheland intermediate. Through this analysis, three residues were identified to be involved in substrate binding across all docked substrates: Y97, P98 and F99, with the two aromatic resides often seen to be sandwiching the substrate ( Supplementary Figs. 1-12 ). Other residues such as L53, I82 and G100 were also frequently implicated in binding the docked compounds, with the predicted binding mainly comprising hydrophobic contacts ( Supplementary Figs. 1-12 ).
The docking experiments support binding in a cleft with access to K79 and E358, similarly to characterized complex structures of FDH-substrate complexes 4 . Several further residues implicated in binding reinforced the extensive active site cavity that enable the strikingly broad substrate flexibility ( Supplementary Fig. 12 ). It is likely that oxidation potential dictates the preference for halide utilization (as indicated by I > Br > Cl) and that it is this enlarged cavity that enables halogenation through a bulky iodamine species.
Conclusions
Our results reveal catalytically notable regioselective halogenations by an FDH, with a viral-derived enzyme demonstrating a preference for iodination. Notably, we also show that by extending the substrate scope of PrnA, iodination in this system may also be permissible. We demonstrate that VirX1 possesses a very broad substrate flexibility and is able to process sterically and electronically demanding substrates in addition to series of nitrogen and Table 1 | Kinetic parameters for iodination and bromination reactions that are catalysed by VirX1 with selected substrates oxygen heterocycles. This may be attributed to the relatively large and accessible active site that was revealed by the crystal structure, and the high level of conformational flexibility predicted by our modelling studies. We reveal a system that may be used as a biocatalytic tool that enables enzyme-catalysed iodination, selective C-H activation and the generation of highly reactive species that could be used for further functionalization. It is envisioned to be a potentially very powerful tool for enabling modification of natural products in the presence of the living host organism through a living GenoChemetics approach 26 .
The role that marine viruses play in manipulating the metabolism of the cyanobacteria they infect has recently been postulated 27 , and the discovery of an efficient viral halogenase with broad substrate flexibility is therefore interesting. Halogenation of a molecule can subtantially perturb its bioactivity and bioavailability, and iodination can render a molecule highly chemically reactive. Although the levels of iodide in the oceans are very low compared to those for bromide and chloride (0.05 ppm versus 65 ppm and 18,980 ppm, respectively), marine algae and bacteria have been shown to accumulate and use iodide 28, 29 . The naturally broad substrate specificity of this enzyme-encoded in a virus that naturally infects the two most abundant photosynthetic organisms on the planet-is fascinating and leads one to wonder as to what its natural role might be. We are taking steps to explore the impact of this iodinase on cyanobacterial metabolism.
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